AGCT1531 A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Recruiting participants (Starts May. 31, 2017)
Not accepting healthy volunteers
UTSW Principal Investigator: Jonathan Eric Wickiser
Participate
If you are interested in this clinical trial, please contact AMANDA RICHARDS on the Children’s Health Research Team.Call 214-456-6300Email
STU 052017-035
AGCT1531 A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors